Infertility is a pervasive issue worldwide and is estimated to have male factor contributions in 20% to 70% of all couples due to various possible aetiologies (Agarwal et al., 2015;Babakhanzadeh et al., 2020). The demand for assistive reproductive technologies has increased globally as affordability and access to them continue to improve (Inhorn & Patrizio, 2015).Testicular sperm retrieval (TSR) techniques, including testicular sperm aspiration (TESA) and microdissection testicular sperm extraction (micro-TESE), are valuable in the context of severe idiopathic male factor infertility as they enable infertile men to father children when coupled with intracytoplasmic sperm injection (ICSI) (Alharbi et al., 2021;Bernie et al., 2015;Palermo et al., 1992). The use of testicular spermatozoa in ICSI is supported by studies demonstrating that sperm transit in the post-testicular milieu induces sperm DNA damage in certain individuals; extracting testicular sperm bypasses transit associated damage, which is associated with high pregnancy and live birth rates (Aboukhshaba et al., 2021;Greco et al., 2005;Mehta et al., 2015).Ramasamy, et al. evaluated the effects of conventional TESE and micro-TESE and found that micro-TESE was associated with fewer structural changes on ultrasound compared to conventional TESE. In both cases, structural changes persisted up to six months. They also demonstrated a return to pre-micro-TESE testosterone level after 18 months (Ramasamy et al., 2005). Furthermore, a recent review